157 related articles for article (PubMed ID: 33058910)
1. What are the immune responses during the growth of Ehrlich's tumor in ascitic and solid form?
Feitosa IB; Mori B; Teles CBG; Costa AGD
Life Sci; 2021 Jan; 264():118578. PubMed ID: 33058910
[TBL] [Abstract][Full Text] [Related]
2. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of anticancer efficacy of aonitine-containing agent BC1 against ascite and solid forms of Ehrlich's carcinoma.
Dasyukevich OI; Solyanik GI
Exp Oncol; 2007 Dec; 29(4):317-9. PubMed ID: 18199991
[TBL] [Abstract][Full Text] [Related]
4. [Chronobiological analysis of thyroxine action on cell proliferation in the hypotetraploid strain of Ehrlich's ascitic tumor].
Romanov IuA; Stepanenko VA
Biull Eksp Biol Med; 1989 Nov; 108(11):610-2. PubMed ID: 2633828
[TBL] [Abstract][Full Text] [Related]
5. Effect of subchronic aflatoxin exposure on growth and progression of Ehrlich's ascites tumor in mice.
Raisuddin S; Zaidi SI; Singh KP; Ray PK
Drug Chem Toxicol; 1991; 14(1-2):185-206. PubMed ID: 1909623
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.
Kumari M; Purohit MP; Pahuja R; Patnaik S; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2019 Dec; 9(6):1159-1188. PubMed ID: 31440985
[TBL] [Abstract][Full Text] [Related]
7. Effects of Trypanosoma brucei gambiense infections in Microtus montanus on susceptibility to Ehrlich's tumors.
Ackerman SB; Seed JR
Infect Immun; 1976 Feb; 13(2):388-91. PubMed ID: 770326
[TBL] [Abstract][Full Text] [Related]
8. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
9. Variable response of spleen to ehrlich's tumor according to the physical form (ascitic or solid) of the tumor.
Rivenson A; Schnelle V; Moroson H; Madden R; Herp A
Experientia; 1981 Feb; 37(2):195-7. PubMed ID: 7238756
[No Abstract] [Full Text] [Related]
10. Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice.
Singh S; Pandey S; Bhatt AN; Chaudhary R; Bhuria V; Kalra N; Soni R; Roy BG; Saluja D; Dwarakanath BS
PLoS One; 2015; 10(7):e0132089. PubMed ID: 26135741
[TBL] [Abstract][Full Text] [Related]
11. [Effect of substances of bacterial origin on Ehrlich's carcinoma].
Aïzenman BIu; Shvaiger MO; Mandrik TP; Bredikhina AM; Orishchik LF; Kolesova OA; Mishenkova OL; Halkina TO; Zakharova IIa; Rashba OIa; Laushnik HM; Preobrazhenska NIu
Mikrobiol Zh; 1965; 27(6):61-7. PubMed ID: 5869042
[No Abstract] [Full Text] [Related]
12. The influence of calf thymus extract (TFX-POLFA) on growth of the subcutaneous transplant of Ehrlich's carcinoma.
Chłap Z; Jaszcz W; Turowski G
Mater Med Pol; 1984; 16(1):37-42. PubMed ID: 6527572
[No Abstract] [Full Text] [Related]
13. [Role of host cells in suppression of the in vivo multiplication of Ehrlich's ascitic cancer cells by the virus-inhibiting factor or interferon].
Nagano Y; Saito H; Kurashima S; Kumazawa Y
C R Seances Soc Biol Fil; 1979; 173(5):960-6. PubMed ID: 161194
[TBL] [Abstract][Full Text] [Related]
14. [On a new antibiotic of streptomycetic origin active against Ehrlich's ascitic carcinoma].
Bertelli A; Bonmassar E; Montagnani-Marelli A; Zannini E
Arch Ital Patol Clin Tumori; 1967; 10(1):21-8. PubMed ID: 5600138
[No Abstract] [Full Text] [Related]
15. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
Belokhvostov AS; Grikurova NK
Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
[TBL] [Abstract][Full Text] [Related]
16. [The influence of an anabolic hormone (dimethazine) on the immunological state of the mouse toward Ehrlich's ascitic carcinoma].
Bonmassar E; Melan F; Montagnani-Marelli A
Arch Ital Patol Clin Tumori; 1967; 10(1):37-40. PubMed ID: 5600140
[No Abstract] [Full Text] [Related]
17. [Morphological changes of the cells of Ehrlich's experimental ascites carcinoma in the course of immunological lysis].
Chibowski D
Ann Univ Mariae Curie Sklodowska Med; 1964; 19():465-78. PubMed ID: 4159442
[No Abstract] [Full Text] [Related]
18. [Lysosome changes in mice with Ehrlich's ascitic and solid tumors].
Pulido E
Riv Patol Clin Sper; 1966; 7(3):387-90. PubMed ID: 4295912
[No Abstract] [Full Text] [Related]
19. Chemopreventive effect of leflunomide against Ehrlich's solid tumor grown in mice: Effect on EGF and EGFR expression and tumor proliferation.
Bahr HI; Toraih EA; Mohammed EA; Mohammad HM; Ali EA; Zaitone SA
Life Sci; 2015 Nov; 141():193-201. PubMed ID: 26439991
[TBL] [Abstract][Full Text] [Related]
20. [An experimental model of metastatic liver involvement by using Ehrlich's ascitic cancer].
Udintsev SN; Fomina TI; Razina TG
Vopr Onkol; 1992; 38(6):723-6. PubMed ID: 1300773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
